Coq10 Interactions

Atorvastatin inhibits HMG-CoA reductase, the same upstream enzyme required to synthesize coenzyme Q10 (ubiquinone). Plasma CoQ10 levels can drop by 30-40% with atorvastatin therapy, and the resulting mitochondrial dysfunction is one proposed mechanism for statin-associated muscle symptoms.

Simvastatin inhibits HMG-CoA reductase, the enzyme upstream of both cholesterol and coenzyme Q10 synthesis. This produces a measurable decline in circulating CoQ10 and may contribute to mitochondrial dysfunction underlying statin-associated muscle symptoms.

Rosuvastatin blocks HMG-CoA reductase, an enzyme required for both cholesterol and coenzyme Q10 synthesis. Although the CoQ10 depletion is generally smaller than with lipophilic statins, mitochondrial impairment is still one proposed mechanism for statin-associated muscle symptoms.

Beta-blockers like metoprolol inhibit CoQ10-dependent mitochondrial enzymes, gradually depleting CoQ10 levels in heart tissue and potentially contributing to fatigue, exercise intolerance, and reduced cardiac energy production. CoQ10 supplementation does not reduce metoprolol's blood pressure or heart rate effects but may offset these mitochondrial side effects.

Grapefruit may slightly increase CoQ10 absorption.

Hawthorn (Crataegus) flavonoids improve myocardial contractility and coronary blood flow through mild ACE inhibition and vasodilation, while CoQ10 supports cardiac ATP production in the electron transport chain. Together they address both the mechanical and metabolic demands of the failing or stressed heart.

CoQ10 shuttles electrons in the mitochondrial electron transport chain to produce ATP, while PQQ activates PGC-1alpha to stimulate the biogenesis of new mitochondria. Used together they support both the quantity and efficiency of cellular energy production.

Niacin (vitamin B3) is the precursor to NAD+ and NADH, the electron carriers that feed into Complex I of the mitochondrial electron transport chain where CoQ10 shuttles those electrons toward ATP synthesis. Together they support different stages of the same energy-producing pathway.

Acetyl-L-carnitine (ALCAR) shuttles long-chain fatty acids into the mitochondrial matrix where they can be beta-oxidized, and CoQ10 then carries the electrons generated by that oxidation through the electron transport chain. The two are functionally complementary along the same energy-production pathway, and combination products have shown benefits in mitochondrial-dysfunction contexts like chronic fatigue and drug-induced hepatotoxicity.